HER2-POSITIVE GASTROESOPHAGEAL JUNCTION

Clinical trials for HER2-POSITIVE GASTROESOPHAGEAL JUNCTION explained in plain language.

Never miss a new study

Get alerted when new HER2-POSITIVE GASTROESOPHAGEAL JUNCTION trials appear

Sign up with your email to follow new studies for HER2-POSITIVE GASTROESOPHAGEAL JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a targeted cancer drug deliver in the real world?

Disease control Recruiting now

This observational study is tracking 260 adults in China with HER2-positive gastric or gastroesophageal junction cancer that is locally advanced or has spread. Participants are receiving trastuzumab deruxtecan (T-DXd) as part of their routine care, and researchers are collecting …

Matched conditions: HER2-POSITIVE GASTROESOPHAGEAL JUNCTION

Sponsor: Daiichi Sankyo • Aim: Disease control

Last updated Aug 19, 2026 09:00 UTC

HER2-POSITIVE GASTROESOPHAGEAL JUNCTION

Get alerted when new HER2-POSITIVE GASTROESOPHAGEAL JUNCTION trials appear

Can a targeted cancer drug deliver in the real world?